Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-06

FDA Approved: TRIAMTERENE — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

The FDA approved Biocon Pharma Inc.'s original ANDA for Triamterene, granting generic approval to market Triamterene.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triamterene (triamterene)

Snippet

ORIG AP for TRIAMTERENE (TRIAMTERENE)